Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Azenta, Inc. (AZTA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.8M | $573.4M | $551.5M | $555.5M | $513.7M | $388.5M | $334.2M | $631.6M | $527.5M | $434.0M | $552.7M | $482.8M | $422.4M | $489.0M | $688.1M | $593.0M | $218.7M |
| Gross profit | $270.3M | $254.6M | $239.2M | $255.6M | $243.8M | $172.1M | $134.6M | $246.1M | $198.9M | $156.7M | $189.1M | $167.3M | $132.3M | $159.5M | $223.0M | $166.3M | −$6.0M |
| Research & development | $30.4M | $31.5M | $32.1M | $27.5M | $22.4M | $17.8M | $17.3M | $46.9M | $39.9M | $44.2M | $52.2M | $52.6M | $46.2M | $44.7M | $39.8M | $31.2M | $31.6M |
| Operating expenses | $297.1M | $305.9M | $300.5M | $280.3M | $274.9M | $208.7M | $182.0M | $214.7M | $184.6M | $173.7M | $172.2M | $170.0M | $149.1M | $157.8M | $143.4M | $119.3M | $222.0M |
| Operating income | −$26.8M | −$51.3M | −$61.2M | −$24.7M | −$31.1M | −$36.6M | −$47.4M | $31.4M | $14.3M | −$17.1M | $16.9M | −$2.7M | −$16.8M | $1.6M | $79.6M | $47.0M | −$228.0M |
| EBITDAderived | $34.4M | $39.5M | $24.3M | $29.0M | $34.2M | $28.9M | $7.0M | $68.8M | $42.5M | $11.0M | $42.0M | $20.8M | $7.4M | $23.3M | $96.8M | $65.4M | −$202.2M |
| Net income | −$55.8M | −$164.9M | −$14.6M | $2.13B | $110.7M | $64.9M | $437.4M | $116.6M | $62.6M | −$69.5M | $14.2M | $31.4M | −$2.2M | $136.8M | $130.4M | $59.8M | −$227.9M |
| Basic EPSper diluted share | -$1.22 | -$3.10 | -$0.22 | $28.48 | $1.49 | $0.88 | $6.08 | $1.65 | $0.90 | -$1.01 | $0.21 | $0.47 | -$0.03 | $2.10 | $2.02 | $0.94 | -$3.62 |
| Diluted EPSper diluted share | -$1.22 | -$3.10 | -$0.22 | $28.48 | $1.49 | $0.88 | $6.04 | $1.64 | $0.89 | -$1.01 | $0.21 | $0.46 | -$0.03 | $2.08 | $2.01 | $0.93 | -$3.62 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026Form 4 | Cornog William LDirector | BuyCommon · indirect | 10.0K | $16.38 | $163.8K | 19.7K |
| Sep 10, 2025Form 4 | Marotta JohnPresident and CEO | SellCommon | 316 | $29.41 | $9.3K | 106.0K |
| Aug 12, 2025Form 4/A | Pirogova OlgaSVP and CHRO | SellCommon | 1.1K | $28.54 | $31.0K | 18.3K |
| Aug 12, 2025Form 4/A | Zhou GingerSVP and GM, Multiomics | SellCommon | 1.1K | $28.54 | $31.0K | 26.8K |
| Aug 11, 2025Form 4 | Lin Lawrence Y.EVP, CFO and Treasurer | BuyCommon | 2.5K | $27.96 | $69.9K | 46.0K |